| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |